NCT05110885

Brief Summary

The addition of SMA and DMD muscle diseases to newborn screening and premarital carrier screening has been controversial. In this study, researchers aim to measure the awareness level of SMA and DMD muscle diseases of individuals living in Turkey and to obtain information about their attitudes towards newborn and carrier screening and physiotherapy practices. Thus, this study aimed to determine the factors that affect people's views on this subject.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2021

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 8, 2021

Completed
24 days until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 8, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

November 10, 2021

Status Verified

November 1, 2021

Enrollment Period

2 months

First QC Date

October 8, 2021

Last Update Submit

November 8, 2021

Conditions

Keywords

AwarenessDuchenne muscular dystrophySpinal muscular atrophyPhysiotheraphyGenetic Carrier ScreeningPrenatal Diagnosis

Outcome Measures

Primary Outcomes (3)

  • Awareness level of community on the SMA and DMD diseases.

    Questionnaire

    Day 1.

  • Attitudes of community towards SMA/DMD newborn screening and carrier screening.

    Questionnaire

    Day 1.

  • Public opinion towards the effectiveness of physiotherapy and rehabilitation on DMD/SMA.

    Questionnaire

    Day 1.

Study Arms (1)

Individuals living in Turkey

Individuals from different regions of Turkey who meet inclusion criteria

Other: Questionnaire

Interventions

A questionnaire prepared by the researchers will be presented to the group.

Individuals living in Turkey

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Individuals from different regions of Turkey who meet inclusion criteria

You may qualify if:

  • All man and women 18-50 years old
  • Volunteering to participate in the study
  • Live in Turkey
  • Being able to read and understand survey questions

You may not qualify if:

  • Refusal to participate
  • Cognitive impairment preventing understanding of the questionnaire and self-reporting

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Muscular Atrophy, SpinalMuscular Dystrophy, Duchenne

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesMotor Neuron DiseaseNeurodegenerative DiseasesNeuromuscular DiseasesMuscular DystrophiesMuscular Disorders, AtrophicMuscular DiseasesMusculoskeletal DiseasesGenetic Diseases, X-LinkedGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

October 8, 2021

First Posted

November 8, 2021

Study Start

November 1, 2021

Primary Completion

January 1, 2022

Study Completion

January 1, 2022

Last Updated

November 10, 2021

Record last verified: 2021-11